Clinical Trial Update: Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients [NA]

View source ↗

Summary

Clinical trial evaluating everolimus (Zortress) plus tacrolimus versus standard immunosuppression in de novo renal transplant recipients, focusing on progressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease
• End-stage Renal Disease
• Renal Osteodystrophy

Drugs mentioned

• Tacrolimus (Tacrolimus)
• Zortress (everolimus)

Snippet

Sponsor: University of Kentucky | Conditions: Renal Transplant | NA | Status: WITHDRAWN